|
... strategy, industry observers have long held that drug companies will eventually warm to pharmacogenetics strategies in order to reduce attrition rates and run more cost-effective clinical trials. Several pharmas, like Pfizer, Bristol-Myers Squibb, Novartis, and even Lilly, have tepidly acknowledged that they are experimenting with PGx internally, while still keeping an eye on the blockbuster ...
Tags:
discount pharmacy

http://2martinlee.livejournal.com/47994.html
(Cached)
0 links
Published: 8 months, 1 week ago (Thu, 06 Nov 2008 11:42:57 PST); 2076 bytes
|